Products & ServicesEvent: September 4, 2026
KalVista Pharmaceuticals, Inc. successfully launched EKTERLY.
Published
Signal category
Products & Services
Quote
“successfully launched EKTERLY”
— Keith Tennison|KalVista Pharmaceuticals, Inc. team
Company
KalVista Pharmaceuticals, Inc.
Advancing novel medicines to empower everyday lives.
- Industry
- Biotechnology Research
- Location
- Framingham, US
- Company size
- 255 employees
For nearly a decade, KalVista Pharmaceuticals has been focused on addressing the critical unmet needs of those living with hereditary angioedema (HAE). With more than 250 employees worldwide, we leverage our team’s vast knowledge and expertise across all aspects of research, development, and commercialization to redefine the future of HAE treatment and advance global care for those who need it most.